Nr. | Numele studiului | Status | Locatia/Locatiile studiului |
1 | Randomized, Double-blind Study Comparing Tremelimumab to Placebo in Subjects With Unresectable Malignant Mesothelioma (Tremelimumab) | Activ, inca nu se recruteaza | Research Site, Craiova, Romania, 200385 |
2 | Study of Nivolumab Combined With Ipilimumab Versus Pemetrexed and Cisplatin or Carboplatin as First Line Therapy in Unresectable Pleural Mesothelioma Patients (CheckMate743) | Activ, inca nu se recruteaza | Local Institution, Bucharest, Romania, 020122Local Institution, Bucuresti, Romania, 021389Local Institution, Craiova, Romania, 200347Local Institution, Romania, Romania, 400015 |
(Visited 52 times, 1 visits today)